Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We are looking to see how the addition of nitrosomonas alters the presence of nitrolipids and inflammatory cytokines on the skin.
We are looking to see how the nitrosomonas alters nitrolipids in the skin and the inflammatory cytokines of the skin.
We will be using healthy subjects over the course of 2 weeks.
Subjects will be using a neutral cleanser for one week prior to the study, skin microbiome,facial photography, lipid and cytokine measurements will be taken at baseline. Subjects will then start using nitrosomonas spray twice daily for one week.
There is a portion of the study where the subjects will have skin microbiome, facial photography, lipid measurements, blood pressure measurements and a bloow draw before and after using the nitrosomonas spray for one week.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Nitrosomonas eutropha spray | Other | Subjects will receive nitrosmonas eutropha spray that they will apply twice a day. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nitrosomonas eutropha | Drug | Subjects will get nitrosomonas eutropha to apply for one week. There is only one arm to this study. Subjects will apply the medication twice a day for one week. |
| Measure | Description | Time Frame |
|---|---|---|
| Alteration in microbiome diversity and species | We will assess the alteration in the skin microbiome over a one week period by assessing the Shannon Diversity Index | one week |
| Alteration in nitrolipids in the skin | we will assess the change in nitrolipid profile of sebum collections from the skin after application of the nitrosomonas spray. | one week |
| Measure | Description | Time Frame |
|---|---|---|
| Alteration in skin cytokines | we will assess the change in skin cytokines with the use of a non-invasive skin collection. | one week |
| Alteration in blood lipids | we will assess the change in blood lipids by performing a blood draw |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Raja K Sivamani, MD | UC Davis | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, Davis Dermatology Clinical Trials Unit | Sacramento | California | 95816 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007249 | Inflammation |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
15 healthy controls will participate in the study Another set of healthy controls (n=20) will be recruited so that they participate in blood draws.
Not provided
Not provided
Not provided
Not provided
| one week |
| Blood pressure readings | blood pressure readings will be performed throughout the study | one week |